Comparison of pulmonary function, respiratory symptoms, functional level, and health-related quality of life in patients with systemic sclerosis according to smoking status

References

• Aktan R, Ozalevli S, Ozakbas S 2018 Effects of cigarette smoking on respiratory problems and functional levels in multiple sclerosis patients. Multiple Sclerosis and Related Disorders 25: 271–275. doi:10.1016/j.msard.2018.08.016.
   PubMed Web of Science ®Google Scholar
• Alivernini S, De Santis M, Tolusso B, Mannocci A, Bosello SL, Peluso G, Pinnelli M, D’Antona G, La Torre G, Ferraccioli G 2009 Skin ulcers in systemic sclerosis: Determinants of presence and predictive factors of healing. Journal of the American Academy of Dermatology 60: 426–435. doi:10.1016/j.jaad.2008.11.025.
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA 1999 Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54: 581–586. doi:10.1136/thx.54.7.581.
   PubMed Web of Science ®Google Scholar
• Çağliyan Türk A, Arslan S, Karavelioğlu Y, Kalcik M, Özel S, Musmul A, Şahin F 2019 Pulmonary function, aerobic capacity and related variables in patients with ankylosing spondylitis. Archives of Rheumatology 34: 317–325. doi:10.5606/ArchRheumatol.2019.7145.
   PubMed Web of Science ®Google Scholar
• Chaudhary P, Chen X, Assassi S, Gorlova O, Draeger H, Harper BE, Gonzalez E, McNearney T, Perry M, Arnett FC, et al. 2016 Cigarette smoking is not a risk factor for systemic sclerosis. Arthritis and Rheumatology 63: 3098–3102. doi:10.1002/art.30492.
   Google Scholar
• Corcioli AC, Pessoa-Santos BV, Takara GN, Lorenzo VA, Jamami M 2017 Reported dyspnea and fatigue using different scales during the physical effort in COPD. Fisioterapia em Movimento 30: 207–217. doi:10.1590/1980-5918.030.002.ao01.
   Google Scholar
• D’Angelo WA, Fries JF, Masi AT, Shulman LE 1969 Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. American Journal of Medicine 46: 428–440. doi:10.1016/0002-9343(69)90044-8.
   PubMed Web of Science ®Google Scholar
• de Miguel Díez J, Esteban Y, Peña MM, Maestu L, Barrera V, Garrido P, Alvarez-Sala Walther LA, García R 2010 Relationship between tobacco consumption and health-related quality of life in adults living in a large metropolitan area. Lung 188: 393–399. doi:10.1007/s00408-010-9256-1.
   PubMed Web of Science ®Google Scholar
• Gabrielli A, Avvedimento EV, Krieg T 2009 Scleroderma. New England Journal of Medicine 360: 1989–2003. doi:10.1056/NEJMra0806188.
   PubMed Web of Science ®Google Scholar
• Galie N, Humbert M, Vachiery JL 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint Task force for the diagnosis and treatment of pulmonary hypertension of the European Society of cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Pediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European Heart Journal 2016: 67–119.
   Google Scholar
• Greenwald GI, Tashkin DP, Gong H, Simmons M, Duann S, Furst DE, Clements P 1987 Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study. American Journal of Medicine 83: 83–92. doi:10.1016/0002-9343(87)90501-8.
   PubMed Web of Science ®Google Scholar
• Hauptmann M, Lubin JH, Rosenberg P, Wellmann J, Kreienbrock L 2000 The use of sliding time windows for the exploratory analysis of temporal effects of smoking histories on lung cancer risk. Statistics in Medicine 19: 2185–2194. doi:10.1002/1097-0258(20000830)19:16<2185::AID-SIM528>3.0.CO;2-I.
   PubMed Web of Science ®Google Scholar
• Herrick AL, Matucci Cerinic M 2001 The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clinical and Experimental Rheumatology 19: 4–8.
   PubMed Web of Science ®Google Scholar
• Hudson M, Lo E, Baron M, Steele R; Canadian Scleroderma Research Group 2011a Modeling smoking in systemic sclerosis: A comparison of different statistical approaches. Arthritis Care Research 63: 570–578. Doi: 10.1002/acr.20416.
   Web of Science ®Google Scholar
• Hudson M, Lo E, Lu Y, Hercz D, Baron M, Steele R; Canadian Scleroderma Research Group 2011b Cigarette smoking in patients with systemic sclerosis. Arthritis and Rheumatology 63: 230–238. Doi: 10.1002/art.30071.
   PubMed Web of Science ®Google Scholar
• Jansen DF, Schouten JP, Vonk JM, Rijcken B, Timens W, Kraan J, Weiss ST, Postma DS 1999 Smoking and airway hyperresponsiveness especially in the presence of blood eosinophilia increase the risk to develop respiratory symptoms: A 25-year follow-up study in the general adult population. American Journal of Respiratory and Critical Care Medicine 160: 259–264. doi:10.1164/ajrccm.160.1.9811015.
   PubMed Web of Science ®Google Scholar
• Konkolÿ Thege B, Stauder A, Kopp MS 2010 Relationship between meaning in life and intensity of smoking: Do gender differences exist? Psychology & Health 25: 589–599. doi:10.1080/08870440802460442.
   PubMed Web of Science ®Google Scholar
• Krzyzanowski M, Lebowitz MD 1992 Changes in chronic respiratory symptoms in two populations of adults studied longitudinally over 13 years. European Respiratory Journal 5: 12–20.
   PubMed Web of Science ®Google Scholar
• Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, et al. 2005 Standardisation of the single-breath determination of carbon monoxide uptake in the lung. European Respiratory Journal 26: 720–735. doi:10.1183/09031936.05.00034905.
   PubMed Web of Science ®Google Scholar
• Miedinger D, Chhajed PN, Karli C, Lupi GA, Leuppi JD 2006 Respiratory symptoms and smoking behaviour in Swiss conscripts. Swiss Medical Weekly 136: 659–663.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. 2005 Standardization of spirometry. European Respiratory Journal 26: 319–338. doi:10.1183/09031936.05.00034805.
   PubMed Web of Science ®Google Scholar
• Ockene IS, Miller NH 1997 Cigarette smoking, cardiovascular disease, and stroke: A statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 96: 3243–3247. doi:10.1161/01.cir.96.9.3243.
   PubMed Web of Science ®Google Scholar
• Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, et al. 2012 An official American Thoracic Society statement: Update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine 185: 435–452. doi:10.1164/rccm.201111-2042ST.
   PubMed Web of Science ®Google Scholar
• Perelas A, Silver RM, Arrossi AV, Highland KB 2020 Systemic sclerosis-associated interstitial lung disease. Lancet Respiratory Medicine 8: 304–320. doi:10.1016/S2213-2600(19)30480-1.
   PubMed Web of Science ®Google Scholar
• Petrie K, Abramson MJ, Cross AJ, George J 2020 Predicting life expectancy of older people using respiratory symptoms and smoking status: Data from the Australian Longitudinal Study of Ageing. Respirology 25: 267–274. doi:10.1111/resp.13603.
   PubMed Web of Science ®Google Scholar
• Pontifex EK, Hill CL, Roberts-Thomson P 2007 Risk factors for lung cancer in patients with scleroderma: A nested case-control study. Annals of Rheumatic Diseases 66: 551–553. doi:10.1136/ard.2006.056424.
   PubMed Web of Science ®Google Scholar
• Pope J 2011 Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler’s Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud’s Condition Score (RCS). Arthritis Care Research 63: S98–S111. doi:10.1002/acr.20598.
   PubMed Web of Science ®Google Scholar
• Schober P, Boer C, Schwarte LA 2018 Correlation coefficients: Appropriate use and interpretation. Anesthesia and Analgesia 126: 1763–1768. doi:10.1213/ANE.0000000000002864.
   PubMed Web of Science ®Google Scholar
• Sokolove J, Wagner CA, Lahey LJ, Sayles H, Duryee MJ, Reimold AM, Kerr G, Robinson WH, Cannon GW, Thiele GM, et al. 2016 Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: A cross-sectional analysis of US veterans. Rheumatology 255: 1969–1977. doi:10.1093/rheumatology/kew285.
   Google Scholar
• Steen VD, Owens GR, Fino GJ, Rodnan GP, Medsger TA 1985 Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis and Rheumatology 28: 759–767. doi:10.1002/art.1780280706.
   PubMed Web of Science ®Google Scholar
• Struthers GR, Scott DL, Delamere JP, Sheppeard H, Kitt M 1981 Smoking and rheumatoid vasculitis. Rheumatology International 1: 145–146. doi:10.1007/BF00541260.
   PubMed Web of Science ®Google Scholar
• Temiz Karadag D, Karakas F, Tekeoglu S, Yazici A, Isik OO, Cefle A 2019 Validation of Turkish version of the. Scleroderma Health Assessment Questionnaire Clinical Rheumatology 38: 1917–1923. doi:10.1007/s10067-019-04494-5.
   PubMed Web of Science ®Google Scholar
• Thombs BD, Hudson M, Bassel M, Taillefer SS, Baron M; Canadian Scleroderma Research Group 2009 Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: Evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis and Rheumatology 61: 966–973. Doi: 10.1002/art.24614.
   PubMedGoogle Scholar
• Traber MG, van der Vliet A, Reznick AZ, Cross CE 2000 Tobacco-related diseases. Is there a role for antioxidant micronutrient supplementation? Clinics in Chest Medicine 21: 173–187. doi:10.1016/S0272-5231(05)70016-2.
   PubMed Web of Science ®Google Scholar
• van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA, Carreira PE, et al. 2013 Classification criteria for systemic sclerosis: An American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis and Rheumatology 65: 2737–2747. doi:10.1002/art.38098.
   PubMed Web of Science ®Google Scholar
• Wigley FM, Wise RA, Miller R, Needleman BW, Spence RJ 1992 Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis and Rheumatology 35: 688–693. doi:10.1002/art.1780350614.
   PubMed Web of Science ®Google Scholar
• Young DR, Reynolds K, Sidell M, Brar S, Ghai NR, Sternfeld B, Jacobsen SJ, Slezak JM, Caan B, Quinn VP 2014 Effects of physical activity and sedentary time on the risk of heart failure. Circulation-Heart Failure 7: 21–27. doi:10.1161/CIRCHEARTFAILURE.113.000529.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Zhang L, Huang XL, Duan Y, Yang LJ, Wang J 2017 Association between cigarette smoking and impaired clinical symptoms in systemic sclerosis: A review. Cellular Immunology 318: 1–7. doi:10.1016/j.cellimm.2017.04.002.
   PubMed Web of Science ®Google Scholar